Skip to content
naulon

Not checkedNot checked for notices yet.

Effect of modulating thrombomodulin expression on renal injury in rats with diabetic nephropathy

WANG Wei, Wei, LI Yi, WU Song and 5 more

Di-san junyi daxue xuebao · 2021

doi:10.16016/j.1000-5404.202007105 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Objective To investigate the effect of modulating thrombomodulin (TM) expression on renal injury in a rat model of diabetic nephropathy (DN) and explore the possible mechanism. Methods We examined the expression of liver X receptor-α (LXR-α), TM, coagulation factor XⅢ-A (FXⅢ-A) and CD163 in 25 renal biopsy samples from patients with DN and in 6 normal renal tissue specimens using immunohistochemistry. Twenty-four 12-week-old male db/db mice with DN were randomly assigned into 4 equal groups and treated daily with intragastric administration of normal saline or LXR-α agonist T0901317, or with intravenous injection of an adenoviral vector carrying TM shRNA or the control adenoviral vector for 7 consecutive days; 6 wild-type C57BL6 mice with intragastric saline treatment served as the normal control group. Four weeks after the treatment, the expression of TM, LXR-α, FXⅢ-A and CD163 in the renal tissues of the mice were detected using Western blotting, the levels of tumor necrosis factor-α (TNF-α) and interleukine-6 (IL-6) were detected by ELISA, and the urinary microalbumin level was determined. Results The renal expression levels of TM and LXR-α were decreased (P < 0.05) and those of FXⅢ-A and CD163 were increased significantly (P < 0.05) in the kidney tissues of DN patients compared with normal kidney tissues. In db/db mouse model of DN, the expression levels of TM and LXR-α were positively correlated while those of FXⅢ-A and CD163 were negatively correlated with glomerular filtration rate (P < 0.05). Compared with the wild-type mice, the mouse model of DN showed significantly increased urinary microalbumin levels and serum levels of TNF-α and IL-6, lowered renal expressions of TM and LXR-α, and increased renal expression of FXⅢ-A and CD163; these changes were further exacerbated in the mice treated with Ad-TM shRNA (P < 0.05) but significantly improved in the mouse models treated with T0901317. Conclusion Upregulating TM expression can reduce urinary microalbumin level in db/db mouse model of DN by inhibiting the renal expression of FXⅢ-A and CD163 and downregulating blood levels of inflammatory mediators.

Abstract licence: CC BY

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.